The BAERVELDT® glaucoma implant is popular because it affords the combination of one-quadrant installation and a large surface area.10

Britt MT et al. Ophthalmology. 1999;106(12):2312-2318.

The 350 mm2 Baerveldt® Glaucoma Implants are a safe and effective treatment for intermediate-term intraocular pressure (IOP) control in patients with refractory glaucoma.

Baerveldt® glaucoma implants are an effective and safe surgical procedure for glaucoma refractory to other surgical or medical management methods.11

Krishna R et al. Ophthalmology. 2001;108(3):621-626.

Both the nonocclusive ligature and the fenestration methods [used with the BAERVELDT® glaucoma implant] provide desirable decreases in IOP in the immediate postoperative period and 3 months postoperatively.12

Kansal S et al. J Glaucoma. 2002;11(1):65-70.

To learn more about Baerveldt® glaucoma implants, contact your AMO representative or call 1-800-366-6554 today (outside the USA, call +1-714-247-8200). The Future in Sight is a trademark and the AMO Logo and Baerveldt are registered trademarks of Advanced Medical Optics, Inc. Baerveldt is produced under at least one of the following U.S. Letters of Patents: 5,397,300; 5,558,629; 5,476,445; 5,178,604. Likewise patents pending and foreign equivalents available upon request. ©2004 Advanced Medical Optics, Inc., Santa Ana, CA 92705.